Correlation Between Mediwound and Milestone Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Mediwound and Milestone Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mediwound and Milestone Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mediwound and Milestone Pharmaceuticals, you can compare the effects of market volatilities on Mediwound and Milestone Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mediwound with a short position of Milestone Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mediwound and Milestone Pharmaceuticals.
Diversification Opportunities for Mediwound and Milestone Pharmaceuticals
-0.33 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Mediwound and Milestone is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Mediwound and Milestone Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Milestone Pharmaceuticals and Mediwound is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mediwound are associated (or correlated) with Milestone Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Milestone Pharmaceuticals has no effect on the direction of Mediwound i.e., Mediwound and Milestone Pharmaceuticals go up and down completely randomly.
Pair Corralation between Mediwound and Milestone Pharmaceuticals
Given the investment horizon of 90 days Mediwound is expected to under-perform the Milestone Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Mediwound is 1.52 times less risky than Milestone Pharmaceuticals. The stock trades about -0.05 of its potential returns per unit of risk. The Milestone Pharmaceuticals is currently generating about 0.3 of returns per unit of risk over similar time horizon. If you would invest 143.00 in Milestone Pharmaceuticals on August 30, 2024 and sell it today you would earn a total of 44.00 from holding Milestone Pharmaceuticals or generate 30.77% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mediwound vs. Milestone Pharmaceuticals
Performance |
| Timeline |
| Mediwound |
| Milestone Pharmaceuticals |
Mediwound and Milestone Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mediwound and Milestone Pharmaceuticals
The main advantage of trading using opposite Mediwound and Milestone Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mediwound position performs unexpectedly, Milestone Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Milestone Pharmaceuticals will offset losses from the drop in Milestone Pharmaceuticals' long position.| Mediwound vs. Foghorn Therapeutics | Mediwound vs. Eliem Therapeutics | Mediwound vs. Sutro Biopharma | Mediwound vs. Dyadic International |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |